-
Something wrong with this record ?
Current Treatment of Anterior Communicating Artery Aneurysms: Single Center Study
O. Navrátil, K. Ďuriš, V. Juráň, K. Svoboda, J. Hustý, E. Hovorka, E. Neuman, A. Mrlian, M. Smrčka,
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
- Publication type
- Journal Article MeSH
INTRODUCTION: Anterior communicating artery aneurysms (ACoAAs) are the most frequent intracranial aneurysms treated at neurosurgical departments with a vascular program. MATERIAL AND METHODS: We reviewed patients with ACoAAs in a single institution over ten years (2008-2017). The focus was on the final outcome; complications, age, and clinical condition with respect to modalities were analyzed. RESULTS: A total of 198 patients treated during this period was included in the study: 176 patients had a ruptured ACoAA and 22 had an unruptured ACoAA. Then, 127 (71%) were treated surgically and 51 (29%) by endovascular means. Out of the whole series, a good recovery occurred in 123 patients (62%), moderate disability in 11 (5.5%), severe disability in 19 (10%), vegetative state in 11 (5.5%), and death in 34 (17%). In the 157 patients (72.5%) with a subarachnoid hemorrhage (SAH), both modalities had a favorable outcome: 27.5% had an unfavorable outcome, 12% had complications in surgery versus 17.6% during endovascular treatment. No statistical difference in outcome, complications, and age was noted between modalities. Surgical treatment was more frequently adopted for patients in a better clinical condition (p ≤ 0.05). CONCLUSION: More than two thirds of the patients (72.5%) reached a favorable outcome. There was no difference in age between the treatment modalities. Risks of complications are present and specific for both modalities.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20021896
- 003
- CZ-PrNML
- 005
- 20201204093214.0
- 007
- ta
- 008
- 201125s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/brainsci10080501 $2 doi
- 035 __
- $a (PubMed)32751951
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Navrátil, Ondřej $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
- 245 10
- $a Current Treatment of Anterior Communicating Artery Aneurysms: Single Center Study / $c O. Navrátil, K. Ďuriš, V. Juráň, K. Svoboda, J. Hustý, E. Hovorka, E. Neuman, A. Mrlian, M. Smrčka,
- 520 9_
- $a INTRODUCTION: Anterior communicating artery aneurysms (ACoAAs) are the most frequent intracranial aneurysms treated at neurosurgical departments with a vascular program. MATERIAL AND METHODS: We reviewed patients with ACoAAs in a single institution over ten years (2008-2017). The focus was on the final outcome; complications, age, and clinical condition with respect to modalities were analyzed. RESULTS: A total of 198 patients treated during this period was included in the study: 176 patients had a ruptured ACoAA and 22 had an unruptured ACoAA. Then, 127 (71%) were treated surgically and 51 (29%) by endovascular means. Out of the whole series, a good recovery occurred in 123 patients (62%), moderate disability in 11 (5.5%), severe disability in 19 (10%), vegetative state in 11 (5.5%), and death in 34 (17%). In the 157 patients (72.5%) with a subarachnoid hemorrhage (SAH), both modalities had a favorable outcome: 27.5% had an unfavorable outcome, 12% had complications in surgery versus 17.6% during endovascular treatment. No statistical difference in outcome, complications, and age was noted between modalities. Surgical treatment was more frequently adopted for patients in a better clinical condition (p ≤ 0.05). CONCLUSION: More than two thirds of the patients (72.5%) reached a favorable outcome. There was no difference in age between the treatment modalities. Risks of complications are present and specific for both modalities.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ďuriš, Kamil $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic. Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic.
- 700 1_
- $a Juráň, Vilém $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
- 700 1_
- $a Svoboda, Karel $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
- 700 1_
- $a Hustý, Jakub $u Department of Radiology and Nuclear Medicine, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Radiology and Nuclear Medicine, University Hospital Brno, 62500 Brno, Czech Republic.
- 700 1_
- $a Hovorka, Evžen $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
- 700 1_
- $a Neuman, Eduard $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
- 700 1_
- $a Mrlian, Andrej $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
- 700 1_
- $a Smrčka, Martin $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
- 773 0_
- $w MED00198694 $t Brain sciences $x 2076-3425 $g Roč. 10, č. 8 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32751951 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201204093211 $b ABA008
- 999 __
- $a ind $b bmc $g 1591605 $s 1112568
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 8 $e 20200731 $i 2076-3425 $m Brain sciences $n Brain Sci $x MED00198694
- LZP __
- $a Pubmed-20201125